Overview

Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
This study evaluated the efficacy and safety of amlodipine/benazepril compared with that of enalapril in the treatment of hypertension in African-American patients with type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Benazepril